Did you know? The Altascientist: Scientific Journal is available as an audiobook series. Listen on our website or wherever you get your podcasts:
Subscribe to Altasciences' podcast channel on your favorite streaming provider to never miss a new audiobook release.
|RECENT RELEASE|| |
|ISSUE 36 — Nonclinical Studies in Cell and Gene Therapy: Key Considerations and Regulatory Guidance|
It is estimated that there are more than 6,000 monogenic diseases affecting over 350 million people worldwide. For these diseases, cell and gene therapy may provide a cure.
ABOUT THE ALTASCIENTIST
A scientific journal written by our experts, The Altascientist is a deep dive into the critical processes behind early phase drug development. Available to read or to listen.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.